Steven Projan
Keine laufenden Positionen mehr
Vermögen: 8 732 $ am 31.03.2024
Karriereverlauf von Steven Projan
Ehemalige bekannte Positionen von Steven Projan
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| EVAXION BIOTECH A/S | Director/Board Member | 01.06.2020 | 01.05.2023 |
| Independent Dir/Board Member | 01.06.2020 | 01.05.2023 | |
| Medimmune, Inc. | Chief Tech/Sci/R&D Officer | 01.01.2010 | 01.04.2018 |
| IDENIX PHARMACEUTICALS INC | Director/Board Member | 03.02.2009 | 11.08.2010 |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Corporate Officer/Principal | 01.08.2008 | 01.01.2010 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | 01.01.2008 | 01.01.2010 |
Ausbildung von Steven Projan
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| Massachusetts Institute of Technology | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
| Dänemark | 2 |
Operativ
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 2 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| EVAXION BIOTECH A/S | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA. | Health Technology |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
| Medimmune, Inc. | Health Technology |
- Börse
- Insiders
- Steven Projan
- Erfahrung
